News & Updates

Treatment with oral roflumilast results in reduced body weight and appetite after 24 weeks in patients with psoriasis, a study has shown.

A retrospective review of medical records show that paediatric patients with alopecia areata (AA) in Singapore respond well to currently available treatments.

Treatment with tildrakizumab in patients with moderate-to-severe scalp psoriasis helps reduce scalp itch and improve quality of life when compared with placebo, with no new safety signals, as shown in a phase IIIb study.

Dietary sodium intake, measured through 24-hour urinary sodium excretion, is positively associated with atopic dermatitis (AD), as suggested in a study.

Use of neoadjuvant daromun in addition to surgery is safe and provides survival benefits in patients with resectable, locally advanced melanoma, results of the PIVOTAL study have shown.